Inhibiteurs d'enképhalinase et exploration moléculaire des différences entre sites actifs de l'enképhalinase et de l'enzyme de conversion de l'angiotensine = Enkephalinase inhibitors and molecular exploration of the differences between active sites of enkephalinase and the angiotensin converting enzymeROQUES, B. P.Actualités pharmacologiques. 1984, Vol 37, Num 41, pp 5-31, issn 0567-8854Article

Approaches nouvelles dans la recherche d'analgésiques et d'antihypertenseurs = New approaches in the search for analgesics and artihypertensivesROQUES, B. P.Annales pharmaceutiques françaises. 1991, Vol 49, Num 6, pp 317-326, issn 0003-4509Article

Une approche pluridisciplaire pour appréhender le(s) mécanisme(s) neurotoxique(s) de l'ecstasy et des drogues de synthèse : Ecstasy et drogues de synthèse = Plusridisciplinary approaches to understand the neutoxic effects of ecstasy : Ecstasy and synthesis drugROQUES, B. P; NOBLE, F.Annales pharmaceutiques françaises. 2003, Vol 61, Num 3, pp 157-163, issn 0003-4509, 7 p.Article

Do antigenic peptides have a unique sense of direction inside the MHC binding groove ? A molecular modelling studyGOPALAKRISHNAN, B; ROQUES, B. P.FEBS letters. 1992, Vol 303, Num 2-3, pp 224-228, issn 0014-5793Article

Les toxines tétaniques et botuliniques sont des métallopeptidases à zinc : mécanismes moléculaires et inhibition de leur neurotoxicité = Tetanus and botulinum toxins are zinc metalloproteases : molecular mechanisms and inhibition of neurotoxicityCORNILLE, F; ROQUES, B. P.Journal de la Société de biologie. 1999, Vol 193, Num 6, pp 509-516, issn 1295-0661Article

Association of enkephalin catabolism inhibitors and CCK-B antagonists : A potential use in the management of pain and opioid additionROQUES, B. P; NOBLE, F.Neurochemical research. 1996, Vol 21, Num 11, pp 1397-1410, issn 0364-3190Article

Synthesis of new amino mimicking sulfated and phosphorylated tyrosine residuesMARSEIGNE, I; ROQUES, B. P.Journal of organic chemistry. 1988, Vol 53, Num 15, pp 3621-3624, issn 0022-3263Article

Presence of a histidine at the active site of the neutral endopeptidase-24.11BEAUMONT, A; ROQUES, B. P.Biochemical and biophysical research communications (Print). 1986, Vol 139, Num 2, pp 733-739, issn 0006-291XArticle

Cell surface metallopeptidases involved in blood pressure regulation : Structure, inhibition and clinical perspectivesROQUES, B. P.Pathologie et biologie. 1998, Vol 46, Num 3, pp 191-200, issn 0369-8114Conference Paper

Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in ratsVALVERDE, O; ROQUES, B. P.Neuroscience letters. 1998, Vol 244, Num 1, pp 37-40, issn 0304-3940Article

Nouvelle approche dans la toxicomanie aux opioïdes : Inhibiteurs du catabolisme des enképhalines comme possible produit de substitution : Toxicomanies = New approach to opioid-addiction : enkephalin-degrading enzyme inhibitor as maintenance treatmentNOBLE, F; ROQUES, B. P.Perspectives psychiatriques (Paris). 1997, Vol 36, Num 2, pp 114-119, issn 0031-6032Article

Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsitesLENA, I; ROQUES, B. P; DURIEUX, C et al.Journal of neurochemistry. 1997, Vol 68, Num 1, pp 162-168, issn 0022-3042Article

La nucléocapside du virus humain HIV-1 = Basic features of the nucleocapside of the human immu odeficiency virus type 1DARLIX, J.-L; ROQUES, B.-P.MS. Médecine sciences. 1993, Vol 9, Num 8-9, pp 952-958, issn 0767-0974Article

Study of the bisintercalation of the antitumor drug ditercalinium by ³¹P-NMRDELEPIERRE, M; IGOLEN, J; ROQUES, B. P et al.Biopolymers. 1988, Vol 27, Num 6, pp 957-968, issn 0006-3525Article

CCK_A, but not CCK_B, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101DAUGE, V; CORRINGER, P.-J; ROQUES, B. P et al.Pharmacology, biochemistry and behavior. 1995, Vol 50, Num 2, pp 133-139, issn 0091-3057Article

Modulation of opioid antinociception by CCK at the supraspinal level : evidence of regulatory mechanisms between CCK and enkephalin systems in the control of painNOBLE, F; DERRIEN, M; ROQUES, B. P et al.British journal of pharmacology. 1993, Vol 109, Num 4, pp 1064-1070, issn 0007-1188Article

Functional residues at the active site of aminopeptidase NHELENE, A; BEAUMONT, A; ROQUES, B. P et al.European journal of biochemistry (Print). 1991, Vol 196, Num 2, pp 385-393, issn 0014-2956, 9 p.Article

Neutral endopeptidase 24.11 and angiotensin converting enzyme like activity in calla positive and calla negative lymphoid cellsBEAUMONT, A; BROUET, J. C; ROQUES, B. P et al.Biochemical and biophysical research communications (Print). 1989, Vol 160, Num 3, pp 1323-1329, issn 0006-291XArticle

Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both μ1 and δ opioid receptorsCHURCHILL, L; ROQUES, B. P; KALIVAS, P. W et al.Psychopharmacologia. 1995, Vol 120, Num 3, pp 347-355, issn 0033-3158Article

Solid phase synthesis of peptides containing the non-hydrolysable analog of (O)phosphotyrosine, p(CH₂PO₃H₂)Phe : application to the synthesis of 344-357 sequences of the β₂ adrenergic receptorGARBAY-JAUREGUIBERRY, C; FICHEUX, D; ROQUES, B. P et al.International journal of peptide & protein research. 1992, Vol 39, Num 6, pp 523-527, issn 0367-8377Article

Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of δ and μ opioid receptorsDAUGE, V; ROSSIGNOL, P; ROQUES, B. P et al.Psychopharmacologia. 1989, Vol 99, Num 2, pp 168-175, issn 0033-3158Article

Similar potencies of CCK-8 and its analogue BOC(Nl_e²⁸;Nl_e³¹) CCK_27-33 on the self-stimulation behaviour both are antagonized by a newly synthesized cyclic CCK analogueHEIDBREDER, C; ROQUES, B. P; DE WHITE, P et al.Neuropeptides (Edinburgh). 1989, Vol 13, Num 2, pp 89-94, issn 0143-4179Article

Etude des propriétés fonctionnelles de l'endopeptidase neutre cérébraleWaksman, Gilles; Roques, B. P.1987, 180 p.Thesis

Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slicesMIGAUD, M; ROQUES, B. P; DURIEUX, C et al.Neuropharmacology. 1994, Vol 33, Num 6, pp 737-743, issn 0028-3908Article

RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in ratsMALDONADO, R; GIRDLESTONE, D; ROQUES, B. P et al.Neuroscience letters. 1993, Vol 156, Num 1-2, pp 135-140, issn 0304-3940Article